Pretubulysin: From Hypothetical Biosynthetic Intermediate to Potential Lead in Tumor Therapy

AL Harvey, 2008, Natural products in drug discovery., Drug Disc Tod, 13, 894, 10.1016/j.drudis.2008.07.004

DJ Newman, 2007, Natural products as sources of new drugs over the last 25 years., J Nat Prod, 70, 461, 10.1021/np068054v

JW Li, 2009, Drug discovery and natural products: end of an era or an endless frontier?, Science, 325, 161, 10.1126/science.1168243

J Bérdy, 2005, Bioactive microbial metabolites., J Antibiot (Tokyo), 58, 1, 10.1038/ja.2005.1

W Fenical, 2006, Developing a new resource for drug discovery: marine actinomycete bacteria., Nat Chem Biol, 2, 666, 10.1038/nchembio841

R Garcia, 2010, Expanded phylogeny of myxobacteria and evidence for cultivation of the ‘unculturables’., Mol Phylogenet Evol, 57, 878, 10.1016/j.ympev.2010.08.028

SC Wenzel, 2009, The biosynthetic potential of myxobacteria and their impact in drug discovery., Curr Opin Drug Discov Devel, 12, 220

K Gerth, 2003, Myxobacteria: proficient producers of novel natural products with various biological activities–past and future biotechnological aspects with the focus on the genus Sorangium., J Biotechnol, 106, 233, 10.1016/j.jbiotec.2003.07.015

KJ Weissman, 2010, Myxobacterial secondary metabolites: bioactivities and modes-of-action., Nat Prod Rep, 27, 1276, 10.1039/c001260m

DJ Newman, 2012, Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010., J Nat Prod, 75, 311, 10.1021/np200906s

MS Butler, 2008, Natural products to drugs: natural product-derived compounds in clinical trials., Nat Prod Rep, 25, 475, 10.1039/b514294f

GM Cragg, 2005, Plants as a source of anti-cancer agents., J Ethnopharmacol, 100, 72, 10.1016/j.jep.2005.05.011

C Dumontet, 2010, Microtubule-binding agents: a dynamic field of cancer therapeutics., Nat Rev Drug Discov, 9, 790, 10.1038/nrd3253

G Höfle, 1996, Epothilon A und B – neuartige, 16gliedrige Makrolide mit cytotoxischer Wirkung: Isolierung, Struktur im Kristall und Konformation in Lösung., Angew Chem, 108, 1671, 10.1002/ange.19961081342

R Jansen, 1994, Antibiotics from Gliding Bacteria, LIX. Disorazoles, Highly Cytotoxic Metabolites from the Sorangicin-Producing Bacterium <italic>Sorangium Cellulosum</italic>, Strain So ce12., Liebigs Ann Chem, 759, 10.1002/jlac.199419940802

F Sasse, 2000, Tubulysins, new cytostatic peptides from myxobacteria acting on microtubuli. Production, isolation, physico-chemical and biological properties., J Antibiot (Tokyo), 53, 879, 10.7164/antibiotics.53.879

H Irschik, 1995, Chivosazol A, a new inhibitor of eukaryotic organisms isolated from myxobacteria., J Antibiot (Tokyo), 48, 962, 10.7164/antibiotics.48.962

B Kunze, 1995, Chondramides A approximately D, new antifungal and cytostatic depsipeptides from Chondromyces crocatus (myxobacteria). Production, physico-chemical and biological properties., J Antibiot (Tokyo), 48, 1262, 10.7164/antibiotics.48.1262

F Sasse, 1993, Rhizopodin, a new compound from Myxococcus stipitatus (myxobacteria) causes formation of rhizopodia-like structures in animal cell cultures. Production, isolation, physico-chemical and biological properties., J Antibiot (Tokyo), 46, 741, 10.7164/antibiotics.46.741

A Dömling, 2005, Myxobacterial epothilones and tubulysins as promising anticancer agents., Mol Divers, 9, 141, 10.1007/s11030-005-1542-0

CD Hopkins, 2009, Isolation, biology and chemistry of the disorazoles: new anti-cancer macrodiolides., Nat Prod Rep, 26, 585, 10.1039/b813799b

A Conlin, 2007, Ixabepilone., Nat Rev Drug Discov, 6, 953, 10.1038/nrd2469

A Sandmann, 2004, Identification and analysis of the core biosynthetic machinery of tubulysin, a potent cytotoxin with potential anticancer activity., Chem Biol, 11, 1071, 10.1016/j.chembiol.2004.05.014

A Ullrich, 2009, Pretubulysin, a potent and chemically accessible tubulysin precursor from Angiococcus disciformis., Angew Chem Int Ed Engl, 48, 4422, 10.1002/anie.200900406

HM Peltier, 2006, The total synthesis of tubulysin D., J Am Chem Soc, 128, 16018, 10.1021/ja067177z

D Neri, 2006, Efforts toward the total synthesis of tubulysins: new hopes for a more effective targeted drug delivery to tumors., ChemMedChem, 1, 175, 10.1002/cmdc.200500043

A Ullrich, 2009, Synthesis and Biological Evaluation of Pretubulysins and Derivatives., Eur J Org Chem, 36, 6367, 10.1002/ejoc.200900999

Z Wang, 2007, Structure-activity and high-content imaging analyses of novel tubulysins., Chem Biol Drug Des, 70, 75, 10.1111/j.1747-0285.2007.00541.x

K Kubicek, 2010, The tubulin-bound structure of the antimitotic drug tubulysin., Angew Chem Int Ed Engl, 49, 4809, 10.1002/anie.200906828

KN Bhalla, 2003, Microtubule-targeted anticancer agents and apoptosis., Oncogene, 22, 9075, 10.1038/sj.onc.1207233

MW Khalil, 2006, Mechanism of action of tubulysin, an antimitotic peptide from myxobacteria., ChemBioChem, 7, 678, 10.1002/cbic.200500421

K Bhalla, 1993, Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells., Leukemia, 7, 563

TH Wang, 2000, Paclitaxel-induced cell death: where the cell cycle and apoptosis come together., Cancer, 88, 2619, 10.1002/1097-0142(20000601)88:11<2619::AID-CNCR26>3.0.CO;2-J

DM Hockenbery, 1993, Bcl-2 functions in an antioxidant pathway to prevent apoptosis., Cell, 75, 241, 10.1016/0092-8674(93)80066-N

MV Blagosklonny, 2001, Unwinding the loop of Bcl-2 phosphorylation., Leukemia, 15, 869, 10.1038/sj.leu.2402134

H Yamaguchi, 2002, Bcl-XL protects BimEL-induced Bax conformational change and cytochrome C release independent of interacting with Bax or BimEL., J Biol Chem, 277, 41604, 10.1074/jbc.M207516200

H Yamaguchi, 2002, Epothilone B analogue (BMS-247550)-mediated cytotoxicity through induction of Bax conformational change in human breast cancer cells., Cancer Res, 62, 466

KN Weiderhold, 2006, CB694, a novel antimitotic with antitumor activities., Int J Cancer, 118, 1032, 10.1002/ijc.21424

J Yang, 1997, Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked., Science, 275, 1129, 10.1126/science.275.5303.1129

MS Ola, 2011, Role of Bcl-2 family proteins and caspases in the regulation of apoptosis., Mol Cell Biochem, 351, 41, 10.1007/s11010-010-0709-x

DW Nicholson, 1995, Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis., Nature, 376, 37, 10.1038/376037a0

L Virág, 2002, The therapeutic potential of poly(ADP-ribose) polymerase inhibitors., Pharmacol Rev, 54, 375, 10.1124/pr.54.3.375

H Irschik, 1995, Disorazol A, an efficient inhibitor of eukaryotic organisms isolated from myxobacteria., J Antibiot (Tokyo), 48, 31, 10.7164/antibiotics.48.31

YA Elnakady, 2004, Disorazol A1, a highly effective antimitotic agent acting on tubulin polymerization and inducing apoptosis in mammalian cells., Biochem Pharmacol, 67, 927, 10.1016/j.bcp.2003.10.029

DM Bollag, 1995, Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action., Cancer Res, 55, 2325

EP Rogakou, 2000, Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139., J Biol Chem, 275, 9390, 10.1074/jbc.275.13.9390

CE Redon, 2010, Histone gammaH2AX and poly(ADP-ribose) as clinical pharmacodynamic biomarkers., Clin Cancer Res, 16, 4532, 10.1158/1078-0432.CCR-10-0523

TD Palmer, 2011, Targeting tumor cell motility to prevent metastasis., Adv Drug Del Rev, 63, 568, 10.1016/j.addr.2011.04.008

F van Zijl, 2011, Initial steps of metastasis: cell invasion and endothelial transmigration., Mutat Res, 728, 23, 10.1016/j.mrrev.2011.05.002

H Steinmetz, 2004, Isolation, crystal and solution structure determination, and biosynthesis of tubulysins–powerful inhibitors of tubulin polymerization from myxobacteria., Angew Chem Int Ed Engl, 43, 4888, 10.1002/anie.200460147

JL Burkhart, 2011, Syntheses and Evaluation of Simplified Pretubulysin Analogues., Eur J Org Chem, 16, 3050, 10.1002/ejoc.201100155

CJ Bruns, 1999, <italic>In Vivo</italic> Selection and Characterization of Metastatic Variants from Human Pancreatic Adenocarcinoma by Using Orthotopic Implantation in Nude Mice., Neoplasia, 1, 50, 10.1038/sj.neo.7900005

J Gong, 1994, A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry., Anal Biochem, 218, 314, 10.1006/abio.1994.1184

I Nicoletti, 1991, A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry., J Immunol Methods, 139, 271, 10.1016/0022-1759(91)90198-O

RD Sloboda, 1976, Microtubule-associated proteins and the stimulation of tubulin assembly in vitro., Biochemistry, 15, 4497, 10.1021/bi00665a026

F Gaskin, 1974, Turbidimetric studies of the in vitro assembly and disassembly of porcine neurotubules., J Mol Biol, 89, 737, 10.1016/0022-2836(74)90048-5